This shows you the differences between two versions of the page.
Both sides previous revision Previous revision Next revision | Previous revision | ||
research:project_proposal_template [2015/02/16 19:47] rkboyce |
research:project_proposal_template [2015/02/16 20:45] (current) rkboyce |
||
---|---|---|---|
Line 7: | Line 7: | ||
**Rationale:** Very few studies have been conducted that report on the potential return on investment for pre-emptive pharmacogenomics testing. The studies that have been published suggest that pre-emptive pharmacogenomics testing may produce a return on investment but much depends on if a sufficient number of drugs with pharmacogenes are covered by a single test. Since the current data are limited to relatively localized settings and might not be of generalizable use to other health organizations, it's of interest to implement a new study using the OHDSI research network. | **Rationale:** Very few studies have been conducted that report on the potential return on investment for pre-emptive pharmacogenomics testing. The studies that have been published suggest that pre-emptive pharmacogenomics testing may produce a return on investment but much depends on if a sufficient number of drugs with pharmacogenes are covered by a single test. Since the current data are limited to relatively localized settings and might not be of generalizable use to other health organizations, it's of interest to implement a new study using the OHDSI research network. | ||
- | **Project Lead(s):** Richard D. Boyce, Matthias Samwald, (seeking other collaborators) | + | **Project Lead(s):** Richard D. Boyce, Matthias Samwald, Patrick Ryan, (seeking other collaborators) |
**Coordinating Institution(s):** University of Pittsburgh, Medical University of Vienna | **Coordinating Institution(s):** University of Pittsburgh, Medical University of Vienna | ||
Line 35: | Line 35: | ||
===== Code ===== | ===== Code ===== | ||
- | [[https://github.com/OHDSI/StudyProtocols/]] | + | [[https://github.com/OHDSI/StudyProtocols/tree/master/Proposed%20Study%203%20-%20Incidence%20of%20exposure%20to%20PGx%20drugs|GitHub code for Proposed Study 3 - Incidence of exposure to PGx drugs]] |
===== Discussion ===== | ===== Discussion ===== | ||
Line 41: | Line 41: | ||
===== Datasets Run ===== | ===== Datasets Run ===== | ||
- | * <list your own datasets or leave blank> | + | * Truven CCAE in the IMEDS lab |
+ | * Truven MDCD in the IMEDS lab | ||
+ | * Truven MDCR in the IMEDS lab | ||
~~NOTOC~~ | ~~NOTOC~~ |